Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
393 studies found for:    Chlormethine
Show Display Options
Rank Status Study
21 Active, not recruiting Mesenchymal Stem Cells Therapy for Treatment of Airway Remodeling in Mustard Patients
Condition: Pulmonary Disease
Intervention: Other: mesenchymal stem cell
22 Recruiting Combination Chemotherapy With or Without Radiation Therapy in Treating Young Patients With Favorable-Risk Hodgkin Lymphoma
Condition: Hodgkin Lymphoma
Interventions: Drug: Stanford V Chemotherapy;   Radiation: Radiation Therapy
23 Completed Experimental Denture Pastes
Conditions: Dental Plaque;   Denture Stomatitis;   Oral Candidiasis;   Oral Hygiene
Intervention: Other: Dentifrice
24 Unknown  Effect on QTc, Pharmacokinetics, Safety, and Preliminary Efficacy of Single-agent Palifosfamide-tris in Subjects With Advanced Solid Tumors
Condition: Advanced Solid Tumors
Interventions: Drug: palifosfamide-tris;   Drug: Normal Saline
25 Active, not recruiting
Has Results
Chemotherapy With Low-Dose Radiation for Pediatric Hodgkin Lymphoma
Condition: Hodgkin's Lymphoma
Interventions: Drug: Adriamycin®;   Drug: Vinblastine;   Drug: Nitrogen Mustard;   Drug: Cyclophosphamide;   Drug: Vincristine;   Drug: Bleomycin;   Drug: Etoposide;   Drug: Prednisone;   Biological: G-CSF;   Procedure: Radiotherapy
26 Terminated
Has Results
Palifosfamide in Treating Patients With Recurrent Germ Cell Tumors
Conditions: Adult Central Nervous System Germ Cell Tumor;   Adult Teratoma;   Malignant Extragonadal Germ Cell Tumor;   Malignant Extragonadal Non-Seminomatous Germ Cell Tumor;   Extragonadal Seminoma;   Recurrent Malignant Testicular Germ Cell Tumor;   Recurrent Ovarian Germ Cell Tumor;   Stage IV Extragonadal Non-Seminomatous Germ Cell Tumor;   Stage IV Extragonadal Seminoma;   Stage IV Ovarian Germ Cell Tumor
Intervention: Drug: palifosfamide
27 Active, not recruiting
Has Results
Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Hodgkin's Lymphoma
Condition: Lymphoma
Interventions: Drug: Doxorubicin;   Drug: Bleomycin;   Drug: Vinblastine;   Drug: Dacarbazine;   Drug: Vincristine;   Drug: Mechlorethamine;   Drug: Etoposide;   Drug: Prednisone;   Drug: Cyclophosphamide;   Radiation: Radiotherapy
28 Recruiting Phase 1-2 Study of Total Bone Marrow Irradiation With Helicoidal Tomotherapy in 1st Myeloma Relapse
Condition: Multiple Myeloma in Relapse
Interventions: Drug: Melphalan;   Biological: Autologous Hematopoietic Stem cell
29 Recruiting Auto Transplant High Dose Melphalan vs High Dose Melphalan+Bortezomib in Pts With Multiple Myeloma Age 65 Years or Older
Condition: Multiple Myeloma
Interventions: Drug: Melphalan;   Drug: Bortezomib
30 Active, not recruiting
Has Results
Mismatched Family Member Donor Transplantation for Children and Young Adults With High Risk Hematological Malignancies
Conditions: Leukemia, Acute Lymphocytic (ALL);   Leukemia, Myeloid, Acute(AML);   Leukemia, Myeloid, Chronic(CML);   Juvenile Myelomonocytic Leukemia (JMML);   Hemoglobinuria, Paroxysmal Nocturnal (PNH);   Hodgkin Lymphoma;   Lymphoma, Non-Hodgkin (NHL);   Myelodysplastic Syndrome (MDS)
Interventions: Device: CliniMACS;   Procedure: Stem cell transplantation;   Drug: Fludarabine;   Drug: Thioplex®;   Drug: L-phenylalanine mustard;   Drug: Mycophenolate mofetil;   Drug: Rituxan™;   Drug: Alemtuzumab;   Drug: Cyclophosphamide;   Drug: Anti-thymocyte globulin (Rabbit);   Drug: G-CSF;   Drug: Muromonab
31 Not yet recruiting Effects of Auriculotherapy on Pain and Functional Capacity of Individuals With Chikungunya Fever
Condition: Chikungunya Fever
Interventions: Procedure: True auriculotherapy with seeds;   Procedure: Placebo Auriculotherapy with seeds
32 Completed Noninvasive Positive Pressure Ventilation Using Helium:Oxygen Versus Air:Oxygen in Acute Respiratory Failure in Chronic Obstructive Pulmonary Disease Patients Exposed to Sulfur Mustard
Conditions: Chronic Obstructive Pulmonary Disease;   Bronchiolitis
Intervention: Drug: helium:oxygen
33 Active, not recruiting Intra-arterial Melphalan in Treating Younger Patients With Unilateral Retinoblastoma
Condition: Unilateral Retinoblastoma
Intervention: Drug: Melphalan
34 Completed
Has Results
Melphalan and Panobinostat (LBH589) for the Treatment of Patients With Recurrent Multiple Myeloma
Condition: Multiple Myeloma
Interventions: Drug: Melphalan;   Drug: Panobinostat
35 Completed Study of ZIO-201 in Advanced Sarcoma
Condition: Advanced Sarcoma
Intervention: Drug: ZIO-201
36 Enrolling by invitation Late Function After Surgery for Transposition of the Great Arteries
Condition: Transposition of Great Vessels
37 Terminated Melphalan With BBBD in Treating Patients With Brain Malignancies
Conditions: Brain and Central Nervous System Tumors;   Lymphoma;   Metastatic Cancer
Intervention: Drug: Melphalan
38 Completed A Phase 1 TH-302 Mass Balance Trial
Condition: Solid Tumor
Interventions: Drug: [14C] TH-302 (Label 1);   Drug: [14C] TH-302 (Label 2);   Drug: Unlabeled TH-302
39 Recruiting A Study of Granix to Disrupt the Bone Marrow Microenvironment in Patients With Multiple Myeloma Undergoing Autologous Transplantation
Condition: Multiple Myeloma
Interventions: Drug: Granix;   Drug: High dose melphalan (HDR);   Procedure: Autologous Stem Cell Transplant (ASCT)
40 Suspended Carfilzomib and Melphalan Before Stem Cell Transplant in Treating Patients With Multiple Myeloma
Conditions: DS Stage I Plasma Cell Myeloma;   DS Stage II Plasma Cell Myeloma;   DS Stage III Plasma Cell Myeloma;   Refractory Plasma Cell Myeloma
Interventions: Procedure: Autologous Bone Marrow Transplantation;   Procedure: Autologous Hematopoietic Stem Cell Transplantation;   Drug: Carfilzomib;   Other: Laboratory Biomarker Analysis;   Drug: Melphalan

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.